Other Clinical Trial - Intravitreal Bevacizumab for Diabetic Retinopathy

Status Terminated

Clinical Trial Summary

Background: to evaluate the 3-month efficacy of a single dose of intravitreal bevacizumab on the progression of severe non proliferative diabetic retinopathy, proliferative diabetic retinopathy and active photocoagulated diabetic proliferative by evaluation of ischemic areas and regression of retinal and disc neovasculrization. Methods: 40 patients were enrolled in a prospective, interventional study. Patients were treated with intravitreal bevacizumab 0.1ml (0.25mg). We evaluated visual acuity, neovascularization leakage points, capillary closure ischemic areas and macular edema by clinical examination and fluorescein angiography. A clinical examination was performed at baseline and days 1,14 and 30. Active leakage points were measured by fluorescein angiography at 30 days.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Active Photocoagulated Diabetic Retinopathy
Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Retinal Diseases
Severe Nonproliferative

Clinical Trial Details

NCT number	NCT00600262
Study type	Interventional
Source	Asociación para Evitar la Ceguera en México
Contact
Status	Terminated
Phase	Phase 2/Phase 3
Start date	December 2005
Completion date	June 2006

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01921192` - Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy	Phase 4
Recruiting	`NCT01044875` - Trial of Yellow 577 nm Laser Versus Green 532 nm Laser for Proliferative Diabetic Retinopathy	N/A
Active, not recruiting	`NCT00993525` - Intravitreal Ranibizumab For Persistent New Vessels In Diabetic Retinopathy(Inipe Study)	Phase 1/Phase 2
Completed	`NCT01307072` - Compliance to Ophthalmic Follow-up Examinations and Surgical Outcome for Proliferative Diabetic Retinopathy	N/A
Completed	`NCT01758757` - Comparison of Small-gauge Vitrectomy and Conventional Vitrectomy for Proliferative Diabetic Retinopathy	N/A
Withdrawn	`NCT00600236` - HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population	Phase 3
Completed	`NCT05414149` - Efficacy and Safety Comparison of IVR and IVC Before Vitrectomy in Proliferative Diabetic Retinopathy	N/A
Completed	`NCT05408416` - Comparison of Surgery Outcome Between Preoperative IVR and Intraoperative IVR in PPV for PDR	N/A
Not yet recruiting	`NCT04464694` - Pre-vitrectomy Intravitreal Ranibizumab for Patients With Proliferative Diabetic Retinopathy Combined With Diabetic Macular Edema	Phase 4
Not yet recruiting	`NCT03633266` - Anti-VEGF Instead of Intraoperative PRP in Proliferative Diabetic Retinopathy	N/A
Completed	`NCT03490318` - Effectiveness of Multimodal Imaging for the Evaluation of Retinal Oedema And New vesseLs in Diabetic Retinopathy
Completed	`NCT01627977` - Association of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy	Phase 3
Completed	`NCT00776763` - Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab	Phase 2
Completed	`NCT00682240` - Morphological and Functional Retinal Changes Following Retinal Photocoagulation	Phase 4
Terminated	`NCT00563628` - Changes in Macular Thickness After Patterns Scan Laser	Phase 4
Terminated	`NCT00563043` - Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment	Phase 4
Completed	`NCT00446381` - Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema)	N/A
Completed	`NCT02879422` - Genetic Markers and Proliferative Diabetic Retinopathy	N/A
Enrolling by invitation	`NCT02911311` - Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy	N/A
Recruiting	`NCT05514925` - Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy	Phase 4